175 related articles for article (PubMed ID: 37878899)
21. [Effect of anticancer treatment on leptin level, fat body mass (FM) and lean body mass (LBM)].
Krawczyk-Rybak M; Muszyńska-Rosłan K; Konstantynowicz J; Solarz E; Wołczynski S; Protas P
Med Wieku Rozwoj; 2004; 8(2 Pt 1):297-307. PubMed ID: 15738606
[TBL] [Abstract][Full Text] [Related]
22. Parental functioning during maintenance treatment for childhood acute lymphoblastic leukemia: Effects of treatment intensity and dexamethasone pulses.
Rensen N; Steur LMH; Grootenhuis MA; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Kaspers GJL; van Litsenburg RRL
Pediatr Blood Cancer; 2020 Nov; 67(11):e28697. PubMed ID: 32909677
[TBL] [Abstract][Full Text] [Related]
23. Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.
van Hulst AM; Verwaaijen EJ; Fiocco MF; Pluijm SMF; Grootenhuis MA; Pieters R; van den Akker ELT; van den Heuvel-Eibrink MM
BMC Pediatr; 2021 Sep; 21(1):427. PubMed ID: 34579671
[TBL] [Abstract][Full Text] [Related]
24. Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country.
Barbosa-Cortés L; López-Alarcón M; Mejía-Aranguré JM; Klünder-Klünder M; Del Carmen Rodríguez-Zepeda M; Rivera-Márquez H; de la Vega-Martínez A; Martin-Trejo J; Shum-Luis J; Solis-Labastida K; López-Aguilar E; Matute-González G; Bernaldez-Rios R
BMC Cancer; 2017 Feb; 17(1):125. PubMed ID: 28193268
[TBL] [Abstract][Full Text] [Related]
25. Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.
Yang W; Cai J; Shen S; Gao J; Yu J; Hu S; Jiang H; Fang Y; Liang C; Ju X; Wu X; Zhai X; Tian X; Wang N; Liu A; Jiang H; Jin R; Sun L; Yang M; Leung AWK; Pan K; Zhang Y; Chen J; Zhu Y; Zhang H; Li C; Yang JJ; Cheng C; Li CK; Tang J; Zhu X; Pui CH
Lancet Oncol; 2021 Sep; 22(9):1322-1332. PubMed ID: 34329606
[TBL] [Abstract][Full Text] [Related]
26. Impaired sleep affects quality of life in children during maintenance treatment for acute lymphoblastic leukemia: an exploratory study.
van Litsenburg RR; Huisman J; Hoogerbrugge PM; Egeler RM; Kaspers GJ; Gemke RJ
Health Qual Life Outcomes; 2011 Apr; 9():25. PubMed ID: 21496357
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of parent-reported sleep problems in pediatric patients with acute lymphoblastic leukemia after induction therapy.
Steur LMH; Grootenhuis MA; Van Someren EJW; Van Eijkelenburg NKA; Van der Sluis IM; Dors N; Van den Bos C; Tissing WJE; Kaspers GJL; Van Litsenburg RRL
Pediatr Blood Cancer; 2020 Apr; 67(4):e28165. PubMed ID: 31944548
[TBL] [Abstract][Full Text] [Related]
28. Sleep habits and fatigue of children receiving maintenance chemotherapy for ALL and their parents.
Zupanec S; Jones H; Stremler R
J Pediatr Oncol Nurs; 2010; 27(4):217-28. PubMed ID: 20562390
[TBL] [Abstract][Full Text] [Related]
29. Changes in body mass index in long-term survivors of childhood acute lymphoblastic leukemia treated without cranial radiation and with reduced glucocorticoid therapy.
Touyz LM; Cohen J; Neville KA; Wakefield CE; Garnett SP; Mallitt KA; Grech AM; Cohn RJ
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27862918
[TBL] [Abstract][Full Text] [Related]
30. Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy.
Follin C; Gabery S; Petersén Å; Sundgren PC; Björkman-Burtcher I; Lätt J; Mannfolk P; Erfurth EM
PLoS One; 2016; 11(1):e0147575. PubMed ID: 26824435
[TBL] [Abstract][Full Text] [Related]
31. Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.
Warris LT; van den Heuvel-Eibrink MM; den Hoed MA; Aarsen FK; Pieters R; van den Akker EL
Pediatr Blood Cancer; 2014 Jul; 61(7):1313-8. PubMed ID: 24532490
[TBL] [Abstract][Full Text] [Related]
32. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
J Clin Endocrinol Metab; 1999 Dec; 84(12):4591-6. PubMed ID: 10599724
[TBL] [Abstract][Full Text] [Related]
33. Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.
Labar B; Suciu S; Willemze R; Muus P; Marie JP; Fillet G; Berneman Z; Jaksic B; Feremans W; Bron D; Sinnige H; Mistrik M; Vreugdenhil G; De Bock R; Nemet D; Gilotay C; Amadori S; de Witte T;
Haematologica; 2010 Sep; 95(9):1489-95. PubMed ID: 20378563
[TBL] [Abstract][Full Text] [Related]
34. Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia.
Browne EK; Zhou Y; Chemaitilly W; Panetta JC; Ness KK; Kaste SC; Cheng C; Relling MV; Pui CH; Inaba H
Cancer; 2018 Nov; 124(21):4248-4259. PubMed ID: 30358906
[TBL] [Abstract][Full Text] [Related]
35. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
36. Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
Ramsey LB; Janke LJ; Payton MA; Cai X; Paugh SW; Karol SE; Kamdem Kamdem L; Cheng C; Williams RT; Jeha S; Pui CH; Evans WE; Relling MV
PLoS One; 2015; 10(8):e0135134. PubMed ID: 26252865
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial.
Domenech C; Suciu S; De Moerloose B; Mazingue F; Plat G; Ferster A; Uyttebroeck A; Sirvent N; Lutz P; Yakouben K; Munzer M; Röhrlich P; Plantaz D; Millot F; Philippet P; Dastugue N; Girard S; Cavé H; Benoit Y; Bertrandfor Y;
Haematologica; 2014 Jul; 99(7):1220-7. PubMed ID: 24727815
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.
te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Uitterlinden AG; Hop WC; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2010 May; 95(5):752-9. PubMed ID: 20015871
[TBL] [Abstract][Full Text] [Related]
39. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
[TBL] [Abstract][Full Text] [Related]
40. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
